{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Heart attack and stroke patients are about to get a new blood thinner that may lower their risk of repeat attacks slightly better than aspirin. But doctors must decide if the drug, clopidogrel, which was approved by the Food and Drug Administration on Monday, provides enough extra benefit to justify paying more than the pennies a day that aspirin costs.", "headline": {"main": "U.S. Approves New Version Of Blood Drug"}, "abstract": "Food and Drug Administration approves blood thinner clopidogrel, which may lower risk of repeat heart attacks and strokes slightly better than aspirin at far higher cost; makers Sanofi and Bristol-Myers Squibb Co say they will set price when they begin selling drug, under brand name Plavix, early next year (S)", "print_page": "26", "word_count": "355", "_id": "4fd214308eb7c8105d78c248", "snippet": "Heart attack and stroke patients are about to get a new blood thinner that may lower their risk of repeat attacks slightly better than aspirin.    But doctors must decide if the drug, clopidogrel, which was approved by the Food and Drug...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1997/11/19/us/us-approves-new-version-of-blood-drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "SANOFI SA"}, {"name": "organizations", "value": "BRISTOL-MYERS SQUIBB CO"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "CLOPIDOGREL (DRUG)"}, {"name": "subject", "value": "PLAVIX (DRUG)"}, {"name": "subject", "value": "STROKE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "BLOOD"}, {"name": "subject", "value": "ASPIRIN"}], "byline": null, "document_type": "article", "pub_date": "1997-11-19T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The single-page form, titled ''Request for medication to end my life in a humane and dignified manner,'' is circulating now in the only state ever to legalize assisted suicide. But whether doctors in Oregon will actually do what the law allows them to is suddenly clouded by a threat from Washington. Acting on a request from two Republican members of Congress who oppose the Oregon law, the Federal Drug Enforcement Administration has warned that doctors here who prescribe drugs to help terminally ill patients kill themselves could face severe sanctions.", "headline": {"main": "Threat From Washington Has Chilling Effect on Oregon Law Allowing Assisted Suicide"}, "abstract": "Drug Enforcement Administration warns that Oregon doctors who prescribe drugs to help terminally ill patients kill themselves could face severe sanctions; threat has had chilling effect on Oregon's assisted suicide law; Oregon Medical Association is advising members not to prescribe drugs until issue is settled; DEA made threat at request of Sen Orrin G Hatch and Rep Henry J Hyde; Sen Ron Wyden, angered by maneuver despite his opposition to assisted suicide, joins with Gov John Kitzhaber in urging Atty Gen Janet Reno to oppose sanctions against doctors; Reno says DEA, Justice Department agency, acted without her consent; photo (M)", "print_page": "18", "word_count": 1238, "_id": "4fd203e48eb7c8105d76a686", "snippet": "The single-page form, titled ''Request for medication to end my life in a humane and dignified manner,'' is circulating now in the only state ever to legalize assisted suicide. But whether doctors in Oregon will actually do what the law allows them...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1997/11/19/us/threat-washington-has-chilling-effect-oregon-law-allowing-assisted-suicide.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "KITZHABER, JOHN"}, {"name": "persons", "value": "WYDEN, RON"}, {"name": "persons", "value": "HYDE, HENRY J"}, {"name": "persons", "value": "RENO, JANET"}, {"name": "persons", "value": "HATCH, ORRIN G"}, {"name": "glocations", "value": "OREGON"}, {"name": "organizations", "value": "DRUG ENFORCEMENT ADMINISTRATION"}, {"name": "organizations", "value": "JUSTICE DEPARTMENT"}, {"name": "organizations", "value": "OREGON MEDICAL ASSN"}, {"name": "subject", "value": "DEATH AND DYING"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Timothy", "lastname": "EGAN"}], "original": "By TIMOTHY EGAN"}, "document_type": "article", "pub_date": "1997-11-19T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Last Thursday, the heads of some of the world's largest tire makers, including Goodyear, Pirelli and Michelin, sat together in a Rome hotel to talk tires. Antitrust officials might have suspected the executives of setting prices for, say, next season's radials. But no, the executives were actually here at the behest of political leaders in Europe and the United States, who are asking business leaders on both sides of the Atlantic to come up with suggestions for increasing the already huge $2 trillion in trans-Atlantic trade. The tire executives were among 70 or so corporate leaders, usually bitter rivals, who met American and European Union officials for two days of talks to find areas they agreed on. It was the third round of talks in the Trans-Atlantic Business Dialogue, following meetings in Spain in 1995 and in Chicago last year.", "headline": {"main": "Businessmen Seek Ways To Fire Up Atlantic Trade"}, "abstract": "About 70 European and American executives, at behest of political leaders, meet with European Union officials for two days, Rome, on ways to increase already huge $2 trillion in trans-Atlantic trade; express belief that Trans-Atlantic tariffs, which average about 3 percent, are not barrier to increased commerce; say problem is vast array of regulations on both side of ocean; goal of meeting was to eliminate duplicate regulations and thereby cut costs to business and, eventually consumers; primary method to accomplish this will be 'mutual recognition agreements'; under such agreements, if product or factory passes regulatory approval on one side of Atlantic, it should automatically be accepted on the other (M)", "print_page": "14", "word_count": 876, "_id": "4fd204958eb7c8105d76be2e", "snippet": "Last Thursday, the heads of some of the world's largest tire makers, including Goodyear, Pirelli and Michelin, sat together in a Rome hotel to talk tires. Antitrust officials might have suspected the executives of setting prices for, say, next...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1997/11/15/business/businessmen-seek-ways-to-fire-up-atlantic-trade.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "EUROPE"}, {"name": "organizations", "value": "EUROPEAN UNION"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "CUSTOMS (TARIFF)"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "John", "lastname": "TAGLIABUE"}], "original": "By JOHN TAGLIABUE"}, "document_type": "article", "pub_date": "1997-11-15T00:00:00Z", "section_name": "Business"}], "meta": {"hits": 3, "offset": 0, "time": 41}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}